Sectoral Asset Management Inc Bluebird Bio, Inc. Transaction History

Sectoral Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$34.44 - $43.75 $340,956 - $433,125	-9,900 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$27.12 - $45.97 $268,488 - $455,103	9,900 New	9,900 $604,000
Q4 2018 Feb 12, 2019	SELL	$59.1 - $93.26 $174,758 - $275,769	-2,957 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$88.86 - $117.49 $262,759 - $347,417	2,957 New	2,957 $432,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.